| Original language | English |
|---|---|
| Journal | Journal of Neurology, Neurosurgery and Psychiatry |
| Volume | 91 |
| Issue number | 9 |
| Pages (from-to) | 1007-1009 |
| Number of pages | 3 |
| ISSN | 0022-3050 |
| DOIs | |
| Publication status | Published - 01.09.2020 |
Funding
Funding The LIPCAL-ALS study was an investigator-initiated trial of the German ALS/MND network, with institutional support from the German Research Foundation (DFG, grant number LU 336/16-1). Nutricia GmbH (Erlangen, Germany) provided the dietary supplement at a cost reduction of 15%.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 10 Reduced Inequalities
Research Areas and Centers
- Centers: Center for Neuromuscular Diseases
DFG Research Classification Scheme
- 2.23-07 Clinical Neurology, Neurosurgery and Neuroradiology
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver